Published

Merck Life Science in India, GeNext Genomics sign MoU - Express Pharma

Summary by Express Pharma
Merck Life Science in India signed a Memorandum of Understanding (MoU) with GeNext Genomics, an emerging biotech company. This collaboration aims to combine local expertise with global biomanufacturing capabilities The MoU was signed between Aditya Sharma, Head of Process Solutions, India Region, Merck Life Science; Dr Ashwin Kashikar, Managing Director, Genext Genomics; Supriya Kashikar, Founder & CEO, GeNext Genomics and Ravi Kashikar, Chairma…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)